Health Technology Assessment in Gastrointestinal Oncology

This group is under the direction of Prof. Mário Dinis Ribeiro and comprises a total of 4 integrated members, 7 PhD students and 1 other researcher as collaborator. This group has been delivering several outputs, putting together diverse competences and researchers, in essence as a "network" of different hospitals (particularly with the main cancer center in Portugal – Instituto Português de Oncologia – and the Hospital São João), medical schools and universities establishing further "nodes" with other R&D groups in CINTESIS, in Porto (e.g. IPATIMUP, IT), Portugal or internationally. The Technologies Assessment in Gastrointestinal Oncology (G3 – iGO) group is a unique network for translational research in Gastrointestinal Oncology.

The iGO group has been working during the last decade in diverse settings from scientific and clinical projects, at national or international levels. In the upcoming years, this team wishes to be a relevant national and international player and partner to conduct multicentre prospective studies, rapidly ensuring an adequate and sufficiently large number of patients, to adequately assess the efficacy, accuracy, effectiveness, safety, acceptability and cost-effectiveness of innovative and disruptive technologies for cancer screening, diagnosis and management.

Integrated Members

Francisco Gonçalves   Gil Faria   Manuel Macedo   no photo w   Jorge Canena
Francisco
Gonçalves
  Gil
Faria
  Guilherme
Macedo
  Isabel
Pedroto
  Jorge
Canena

 

Mario Dinis-Ribeiro   no photo m   Pedro Nunes   Ricardo Pinto
Mário
Dinis-Ribeiro [PI]
  Miguel
Areia
  Pedro
Pimentel Nunes
  Ricardo
Marcos-Pinto

Other researchers

  • Amélia Susana dos Santos Brandão Tavares
  • Diogo Miguel Pereira Libânio Monteiro
  • Hélder Manuel Cardoso
  • Matilde Filipa Monteiro Soares
  • Nuno Miguel Teixeira de Sousa
  • Pedro Nuno Valente Reis Pereira

 

 

  g3